Protalix BioTherapeutics Inc. (DE) News
Protalix Bio Cystic Fibrosis Drug Study Results Worsen Over Time
The Protalix medicine alidornase alfa is designed to help cystic fibrosis patients clear their lungs by making mucus thin and loose.
Biotech Stock Mailbag: Bulls love a distracted Trump, Protalix, Acadia, Sarepta
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Why Protalix BioTherapeutics (PLX) Stock Is Surging Today
Protalix BioTherapeutics (PLX) advanced Thursday after the company co-announced with Pfizer (PFE) that the FDA had approved the expansion of ELELYSO for injection in pediatric patients.
Bluebird Bio's 2nd Approval Doesn't Guarantee Survival
Investors hoping for a revival at the struggling biotech might want to temper their expectations.
A’s Likely Headed to Las Vegas Strip After Oakland Drops Ball
A major league sports team is closer than ever to relocating to Las Vegas.